IL-22 program(Synthekine Inc)

N/A

Report date: 2025/10/20 14:18:42

Base Information

Drug NameIL-22 program(Synthekine Inc)

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionInterleukin-22 agonists

TargetsInterleukin-22

Therapy Area/IndicationsInflammationMetabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSynthekine Inc

China Registration ClassN/A

Active CompaniesSynthekine Inc

Inactive CompaniesN/A

Active IndicationsInflammationMetabolic Diseases

Inactive IndicationsN/A

ATC CodeN/A